BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38110397)

  • 21. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
    Wang WH; Duan JX; Vu TH; Hoffman AR
    J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis.
    Okamoto K; Morison IM; Taniguchi T; Reeve AE
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5367-71. PubMed ID: 9144243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic lesions at the H19 locus in Wilms' tumour patients.
    Moulton T; Crenshaw T; Hao Y; Moosikasuwan J; Lin N; Dembitzer F; Hensle T; Weiss L; McMorrow L; Loew T; Kraus W; Gerald W; Tycko B
    Nat Genet; 1994 Jul; 7(3):440-7. PubMed ID: 7920666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study.
    Armstrong AE; Gadd S; Huff V; Gerhard DS; Dome JS; Perlman EJ
    PLoS One; 2018; 13(12):e0208936. PubMed ID: 30543698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in Wilms' tumor predisposition.
    Maciaszek JL; Oak N; Nichols KE
    Hum Mol Genet; 2020 Oct; 29(R2):R138-R149. PubMed ID: 32412586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression of imprinted genes in Wilms tumors.
    Hubertus J; Lacher M; Rottenkolber M; Müller-Höcker J; Berger M; Stehr M; von Schweinitz D; Kappler R
    Oncol Rep; 2011 Mar; 25(3):817-23. PubMed ID: 21174059
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Moore C; Monforte H; Teer JK; Zhang Y; Yoder S; Brohl AS; Reed DR
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32699065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
    Satoh Y; Nakadate H; Nakagawachi T; Higashimoto K; Joh K; Masaki Z; Uozumi J; Kaneko Y; Mukai T; Soejima H
    Br J Cancer; 2006 Aug; 95(4):541-7. PubMed ID: 16909133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P; Telzerow P; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Confirmation of Xp22.11 Duplication as a Germline Susceptibility Alteration in a Wilms Tumor Arising in Horseshoe Kidney.
    Zhou HF; Amarillo IE; Snyder S; Granadillo JL; O'Conor CJ; Dillon P; Wilson D; Huang FS; Dehner LP; He M
    Fetal Pediatr Pathol; 2022 Aug; 41(4):682-688. PubMed ID: 33960268
    [No Abstract]   [Full Text] [Related]  

  • 31. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
    Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
    J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour.
    Sparago A; Russo S; Cerrato F; Ferraiuolo S; Castorina P; Selicorni A; Schwienbacher C; Negrini M; Ferrero GB; Silengo MC; Anichini C; Larizza L; Riccio A
    Hum Mol Genet; 2007 Feb; 16(3):254-64. PubMed ID: 17158821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.
    Dao D; Walsh CP; Yuan L; Gorelov D; Feng L; Hensle T; Nisen P; Yamashiro DJ; Bestor TH; Tycko B
    Hum Mol Genet; 1999 Jul; 8(7):1337-52. PubMed ID: 10369881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor.
    Scott RH; Douglas J; Baskcomb L; Huxter N; Barker K; Hanks S; Craft A; Gerrard M; Kohler JA; Levitt GA; Picton S; Pizer B; Ronghe MD; Williams D; ; Cook JA; Pujol P; Maher ER; Birch JM; Stiller CA; Pritchard-Jones K; Rahman N
    Nat Genet; 2008 Nov; 40(11):1329-34. PubMed ID: 18836444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor.
    Gadd S; Huff V; Walz AL; Ooms AHAG; Armstrong AE; Gerhard DS; Smith MA; Auvil JMG; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Hermida LC; Davidsen T; Gesuwan P; Ma Y; Zong Z; Mungall AJ; Moore RA; Marra MA; Dome JS; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Ross N; Gastier-Foster JM; Arold ST; Perlman EJ
    Nat Genet; 2017 Oct; 49(10):1487-1494. PubMed ID: 28825729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.
    Gadd S; Huff V; Huang CC; Ruteshouser EC; Dome JS; Grundy PE; Breslow N; Jennings L; Green DM; Beckwith JB; Perlman EJ
    Neoplasia; 2012 Aug; 14(8):742-56. PubMed ID: 22952427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.
    Taniguchi T; Sullivan MJ; Ogawa O; Reeve AE
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2159-63. PubMed ID: 7534414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors.
    O'Keefe D; Dao D; Zhao L; Sanderson R; Warburton D; Weiss L; Anyane-Yeboa K; Tycko B
    Am J Hum Genet; 1997 Aug; 61(2):295-303. PubMed ID: 9311733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.
    Fernandez CV; Perlman EJ; Mullen EA; Chi YY; Hamilton TE; Gow KW; Ferrer FA; Barnhart DC; Ehrlich PF; Khanna G; Kalapurakal JA; Bocking T; Huff V; Tian J; Geller JI; Grundy PE; Anderson JR; Dome JS; Shamberger RC
    Ann Surg; 2017 Apr; 265(4):835-840. PubMed ID: 27811504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.